HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Granulocyte-macrophage colony-stimulating factor-induced vessel growth restores cerebral blood supply after bilateral carotid artery occlusion.

AbstractBACKGROUND AND PURPOSE:
Hemodynamic compromise due to occlusive cerebrovascular disease is associated with an increased stroke risk. Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been suggested to stimulate collateral blood vessel growth in various models of hemodynamic compromise. The purpose of this study was to investigate the effects of GM-CSF on cerebral hemodynamics and vessel growth in a rat model of chronically impaired cerebral blood flow (CBF).
METHODS:
Male Sprague-Dawley rats underwent sequential bilateral carotid artery occlusion (BCO) and were treated with GM-CSF or saline for 6 weeks. Sham-occluded animals served as a control group. Baseline CBF was measured by iodo[(14)C]antipyrine autoradiography, and cerebrovascular reserve capacity was assessed by laser-Doppler flowmetry after application of 20 mg/kg body weight acetazolamide. The capillary density and arterioles immunopositive for alpha-smooth muscle actin were counted on brain sections. The cerebral angioarchitecture was visualized with a latex perfusion technique.
RESULTS:
Baseline CBF as measured by iodo[(14)C]antipyrine autoradiography was not affected by BCO. The cerebrovascular reserve capacity, however, was significantly impaired 1 week after BCO. CBF and cerebrovascular reserve capacity recovered completely in GM-CSF-treated animals but not in solvent-treated animals. Histologic analysis of the hippocampus revealed integrity of the hypoxia-vulnerable neurons in all animals. The capillary density showed a very mild increase in GM-CSF-treated animals. However, the number of intraparenchymal and leptomeningeal arterioles was significantly higher in GM-CSF-treated animals than in both other groups.
CONCLUSIONS:
Long-term GM-CSF treatment in a BCO model in rats leads to restoration of impaired cerebral hemodynamics and accompanies structural changes in the resistance-vessel network.
AuthorsUlf C Schneider, Lothar Schilling, Helmut Schroeck, C Thomas Nebe, Peter Vajkoczy, Johannes Woitzik
JournalStroke (Stroke) Vol. 38 Issue 4 Pg. 1320-8 (Apr 2007) ISSN: 1524-4628 [Electronic] United States
PMID17332468 (Publication Type: Journal Article)
Chemical References
  • Angiogenic Proteins
  • Intercellular Signaling Peptides and Proteins
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Acetazolamide
  • Antipyrine
Topics
  • Acetazolamide
  • Angiogenic Proteins (pharmacology, therapeutic use)
  • Animals
  • Antipyrine
  • Capillaries (cytology, drug effects, physiology)
  • Carotid Stenosis (complications, drug therapy, physiopathology)
  • Cerebral Arteries (drug effects, physiopathology)
  • Cerebrovascular Circulation (drug effects, physiology)
  • Cerebrovascular Disorders (drug therapy, etiology, physiopathology)
  • Disease Models, Animal
  • Granulocyte-Macrophage Colony-Stimulating Factor (pharmacology, therapeutic use)
  • Hippocampus (blood supply)
  • Intercellular Signaling Peptides and Proteins (pharmacology, therapeutic use)
  • Laser-Doppler Flowmetry
  • Male
  • Microcirculation (drug effects, physiology)
  • Neovascularization, Physiologic (drug effects, physiology)
  • Rats
  • Rats, Sprague-Dawley
  • Recovery of Function (drug effects, physiology)
  • Time
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: